Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Gly101Val BCL2 Mutation: One Step Closer to Understanding Venetoclax Resistance in CLL.

Thangavadivel S, Byrd JC.

Cancer Discov. 2019 Mar;9(3):320-322. doi: 10.1158/2159-8290.CD-19-0029.

PMID:
30824485
2.

The Impact of Photorefractive Keratectomy and Mitomycin C on Corneal Nerves and Their Regeneration.

Medeiros CS, Marino GK, Lassance L, Thangavadivel S, Santhiago MR, Wilson SE.

J Refract Surg. 2018 Dec 1;34(12):790-798. doi: 10.3928/1081597X-20181112-01. Erratum in: J Refract Surg. 2019 Feb 1;35(2):132.

3.

IL-1 and TGF-β Modulation of Epithelial Basement Membrane Components Perlecan and Nidogen Production by Corneal Stromal Cells.

Saikia P, Thangavadivel S, Medeiros CS, Lassance L, de Oliveira RC, Wilson SE.

Invest Ophthalmol Vis Sci. 2018 Nov 1;59(13):5589-5598. doi: 10.1167/iovs.18-25202.

4.

Basement membranes in the cornea and other organs that commonly develop fibrosis.

Saikia P, Medeiros CS, Thangavadivel S, Wilson SE.

Cell Tissue Res. 2018 Dec;374(3):439-453. doi: 10.1007/s00441-018-2934-7. Epub 2018 Oct 3. Review.

5.

Fibrocyte migration, differentiation and apoptosis during the corneal wound healing response to injury.

Lassance L, Marino GK, Medeiros CS, Thangavadivel S, Wilson SE.

Exp Eye Res. 2018 May;170:177-187. doi: 10.1016/j.exer.2018.02.018. Epub 2018 Feb 24.

6.

Epithelial basement membrane injury and regeneration modulates corneal fibrosis after pseudomonas corneal ulcers in rabbits.

Marino GK, Santhiago MR, Santhanam A, Lassance L, Thangavadivel S, Medeiros CS, Bose K, Tam KP, Wilson SE.

Exp Eye Res. 2017 Aug;161:101-105. doi: 10.1016/j.exer.2017.05.003. Epub 2017 May 13.

7.

T cells in multiple myeloma display features of exhaustion and senescence at the tumor site.

Zelle-Rieser C, Thangavadivel S, Biedermann R, Brunner A, Stoitzner P, Willenbacher E, Greil R, Jöhrer K.

J Hematol Oncol. 2016 Nov 3;9(1):116.

8.

CCR10/CCL27 crosstalk contributes to failure of proteasome-inhibitors in multiple myeloma.

Thangavadivel S, Zelle-Rieser C, Olivier A, Postert B, Untergasser G, Kern J, Brunner A, Gunsilius E, Biedermann R, Hajek R, Pour L, Willenbacher W, Greil R, Jöhrer K.

Oncotarget. 2016 Nov 29;7(48):78605-78618. doi: 10.18632/oncotarget.12522.

9.

Low Beclin-1 expression predicts improved overall survival in patients treated with immunomodulatory drugs for multiple myeloma and identifies autophagy inhibition as a promising potentially druggable new therapeutic target: an analysis from The Austrian Myeloma Registry (AMR).

Willenbacher W, Thangavadivel S, Greil R, Willenbacher E, Weger R, Manzl C, Jöhrer K, Brunner A.

Leuk Lymphoma. 2016 Oct;57(10):2330-41. doi: 10.3109/10428194.2016.1144880. Epub 2016 Feb 16.

PMID:
26880040
10.

Akt-dependent enhanced migratory capacity of Th17 cells from children with lupus nephritis.

Kshirsagar S, Riedl M, Billing H, Tönshoff B, Thangavadivel S, Steuber C, Staude H, Wechselberger G, Edelbauer M.

J Immunol. 2014 Nov 15;193(10):4895-903. doi: 10.4049/jimmunol.1400044. Epub 2014 Oct 22.

11.

Adipocyte-derived players in hematologic tumors: useful novel targets?

Jöhrer K, Ploner C, Thangavadivel S, Wuggenig P, Greil R.

Expert Opin Biol Ther. 2015 Jan;15(1):61-77. doi: 10.1517/14712598.2015.970632. Epub 2014 Oct 11. Review.

PMID:
25308972

Supplemental Content

Loading ...
Support Center